Work

Evaluation of Very High- and Very Low-Dose Intravitreal Aflibercept in Patients with Neovascular Age-Related Macular Degeneration

Year: 2012

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Journal of Ocular Pharmacology and Therapeutics

DOI: 10.1089/jop.2011.0261

Authors: Quan Dong Nguyen, Peter A. Campochiaro, Syed Mahmood Shah, David J. Browning, Henry L. Hudson, Peter L. Sonkin, Seenu M. Hariprasad, Peter K. Kaiser, Jason Slakter, Julia A. Haller, Diana V. Do, William Mieler, Karen Chu, Avner Ingerman, Robert Vitti, Alyson J. Berliner, Jesse Cedarbaum

Institutions: Johns Hopkins University, Johns Hopkins Medicine, Charlotte Eye Ear Nose & Throat Associates, The Retina Center, Tennessee Retina, University of Chicago, Cleveland Clinic, Vitreous Retina Macula Consultants of New York, Regeneron (United States)

Language: English

Topic: Retinal Diseases and Treatments

Subfield: Ophthalmology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Regeneron Pharmaceuticals

OpenAlex ID: W163157393

FWCI: 2.728

Cites: 9

Cited by: 22

Related to: 10